Results 21 to 30 of about 1,273 (215)

Convalescent plasma and all-cause mortality of COVID-19 patients: systematic review and meta-analysis

Scientific Reports, 2023
Insight into the clinical potential of convalescent plasma in patients with coronavirus disease (COVID-19) is important given the severe clinical courses in unvaccinated and seronegative individuals.
Nora Mihalek, Dragana Radovanović, Otto Barak, Petar Čolović, Markus Huber, Gabor Erdoes   +5 more
doaj   +1 more source

Convalescent plasma therapy in COVID-19 critically ill patients during advanced phases of clinical trials and their preliminary results

Einstein (São Paulo), 2021
The objective of this study was to highlight the global scientific effort to fight the SARS-CoV-2, addressing the preliminary results of passive immunization through convalescent plasma.
Fernando Anselmo de Oliveira, Mariana Penteado Nucci, Gabriel Nery de Albuquerque Rego, Arielly da Hora Alves, Luciana Cavalheiro Marti, Leopoldo Penteado Nucci, Javier Bustamante Mamani, Lionel Fernel Gamarra   +7 more
doaj   +2 more sources

Investigation of SARS-CoV-2 RNAemia in the convalescent plasma of COVID-19 patients

International Journal of Infectious Diseases, 2022
Purpose: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is responsible for the ongoing global COVID-19 disease pandemic. Convalescent plasma therapy (CPT) is one of the promising therapies being tried for COVID-19 patients ...
N. Perumal, R.K. Jain, D. Chaurasia, U.M. Sharma, R. Malik   +4 more
doaj   +1 more source

Convalescent plasma: A potential therapeutic option for COVID-19 patients

Asian Pacific Journal of Tropical Medicine, 2020
The new coronavirus disease (COVID-19) outbreak has challenged us to take unprecedented steps to bring this pandemic under control. In view of the urgency of this situation, convalescent plasma which was used in previous coronavirus outbreaks has emerged
Swee Li Ng, Tsuey Ning Soon, Wei Hsum Yap, Kai Bin Liew, Ya Chee Lim, Long Chiau Ming, Yin-Quan Tang, Bey Hing Goh   +7 more
doaj   +1 more source

Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden

BMC Research Notes, 2021
Objective Convalescent plasma has been tried as therapy for various viral infections. Early observational studies of convalescent plasma treatment for hospitalized COVID-19 patients were promising, but randomized controlled studies were lacking at the ...
Karin Holm, Maria N. Lundgren, Jens Kjeldsen-Kragh, Oskar Ljungquist, Blenda Böttiger, Christian Wikén, Jonas Öberg, Nils Fernström, Ebba Rosendal, Anna K. Överby, Julia Wigren Byström, Mattias Forsell, Mona Landin-Olsson, Magnus Rasmussen   +13 more
doaj   +1 more source

Convalescent Plasma in COVID-19

HCA Healthcare Journal of Medicine, 2020
The recent pandemic of SARS-CoV-2, which causes novel coronavirus disease 2019 (Covid-19), has had devastating impact on a global and national scale. In order to overcome this outbreak it is imperative we find treatments that are safe and effective.
Ranjit S, Banwait, Joshua K, Salabei, Troy J, Fishman, Uma G, Iyer   +3 more
openaire   +3 more sources

Case Report: Serial Cases: Prolongation of High Immunoglobulin G Level in Repetitive COVID-19 Convalescence Plasma Donor in Saiful Anwar Hospital Malang, Indonesia

Frontiers in Immunology, 2021
BackgroundConvalescent plasma therapy is expected to be a promising alternative to supportive therapy during the SARS-CoV-2 pandemic outbreak. Altered immune response in repetitive convalescent plasma donors has not been widely studied.
Nina Nurarifah, Herwindo Pudjo Brahmantyo, Shinta Oktya Wardhani, Djoko Heri Hermanto, Putu Moda Arsana   +4 more
doaj   +1 more source

Convalescent plasma therapy in COVID-19 patients: a non-randomized case-control study with concurrent control

Brazilian Journal of Medical and Biological Research, 2022
Convalescent plasma therapy has shown controversial results in coronavirus disease-19 (COVID-19) patients. We performed a non-randomized case-control study with contemporaneous controls in a hospital in southern Brazil.
P. Cacilhas, E. Caberlon, L. Angoleri, K. Fassina, R.N. Ribeiro, L.C. Pinto   +5 more
doaj   +1 more source

Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials

Viruses, 2023
Background: While passive immunotherapy has been considered beneficial for patients with severe respiratory viral infections, the treatment of COVID-19 cases with convalescent plasma produced mixed results.
Charalampos Filippatos, Ioannis Ntanasis-Stathopoulos, Kalliopi Sekeri, Anastasios Ntanasis-Stathopoulos, Maria Gavriatopoulou, Theodora Psaltopoulou, George Dounias, Theodoros N. Sergentanis, Evangelos Terpos   +8 more
doaj   +1 more source

Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial)

Scientific Reports, 2022
There is a need for effective therapy for COVID-19 pneumonia. Convalescent plasma has antiviral activity and early observational studies suggested benefit in reducing COVID-19 severity.
Karin van den Berg, Tanya Nadia Glatt, Marion Vermeulen, Francesca Little, Ronel Swanevelder, Claire Barrett, Richard Court, Marise Bremer, Cynthia Nyoni, Avril Swarts, Cordelia Mmenu, Thomas Crede, Gerdien Kritzinger, Jonathan Naude, Patryk Szymanski, James Cowley, Thandeka Moyo-Gwete, Penny L. Moore, John Black, Jaimendra Singh, Jinal N. Bhiman, Prinita Baijnath, Priyesh Mody, Jacques Malherbe, Samantha Potgieter, Cloete van Vuuren, Shaun Maasdorp, Robert J. Wilkinson, Vernon J. Louw, Sean Wasserman   +29 more
doaj   +1 more source